Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Notice of Special Interest (NOSI): Developing and Delivering Feasible Screening Methods and Tools for Eating Disorders.

National Institutes of Health

The National Institute of Mental Health (NIMH) is issuing this Notice of Special Interest (NOSI) to encourage applications that investigate the development and delivery of screening methods for subthreshold and diagnosable eating disorders in naturalistic settings for children, adolescents, and adults. An emphasis is placed on research that seeks to develop and test low-burden, feasible screening methods, addresses inequities in detection among populations with health disparities, utilizes existing setting staff and/or lay/alternate providers to aid in screening efforts, aims to quantify the resources necessary to implement these approaches, and/or proposes to identify and address factors that hinder/facilitate implementation and scale-up.

NIMH is committed to supporting research that reduces disparities and advances equity in mental health interventions, services, and outcomes. Accordingly, this NOSI encourages research that seeks to reduce disparities in detection for populations with health disparities as defined by NIH ( https://www.nimhd.nih.gov/about/strategic-plan/nih-strategic-plan-definitions-and-parameters.html ), including racial and ethnic minority groups, people with lower socioeconomic status, and sexual and gender minority groups. NIMH encourages projects that (1) develop, deliver, and examine the impact of low-burden and/or innovative screening methods, strategies, and tools to facilitate the detection of subthreshold and diagnostic eating disorders among children, adolescents, and adults, (2) promote health equity amongst populations with health disparities, (3) utilize existing staff and/or lay/alternate providers such as peers, community health workers, and paraprofessionals to aid in screening efforts, (4) quantify the resources necessary to implement these approaches, including training and supervision, administrative/delivery time and burden, and (5) identify and address factors that hinder/facilitate implementation and scale-up.

This notice applies to due dates on or after October 15, 2024, and subsequent receipt dates through May 8, 2027.

NOT-MH-24-380

Specialties

Medical

Medical - Translational

Medical - Clinical Science

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity